CEESAY ABRAHAM (Chief Executive Officer) sold 0.5% of their position (2.21K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $86.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/24/2026ACC: 0001193125-26-401017
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-2.21K
Net shares
Net seller
$86.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
2.21K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.95K
Price / share
$39.05
Trade value
$76.23K
% of position
0.4%
9/23/2026
458.98K→457.02K
Common Stock
Direct
Shares
−215.00
Price / share
$39.86
Trade value
$8.57K
% of position
0.0%
9/23/2026
457.02K→456.81K
Common Stock
Direct
Shares
−43.00
Price / share
$41.05
Trade value
$1.77K
% of position
0.0%
9/23/2026
456.81K→456.77K
Total
Net shares
−2.21K
Net value
-$86.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2026 | S · Sale | −1.95K | $39.05 | $76.23K | 0.4% | 458.98K | 457.02K |
| Common Stock Direct | 9/23/2026 | S · Sale | −215.00 | $39.86 | $8.57K | 0.0% | 457.02K | 456.81K |
| Common Stock Direct | 9/23/2026 | S · Sale | −43.00 | $41.05 | $1.77K | 0.0% | 456.81K | 456.77K |
| Total | −2.21K | -$86.57K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned20.73K
Common Stock
IndirectShares owned81.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20.73K | Indirect |
| Common Stock | 81.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported